Stay updated with breaking news from Accelerate Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Rating) was the recipient of a large decline in short interest in March. As of March 31st, there was short interest totalling 4,760,000 shares, a decline of 6.1% from the March 15th total of 5,070,000 shares. Based on an average daily volume of 293,900 shares, the short-interest ratio is […]
Global Antibiotic Resistance Diagnostic Market
Operator: Good afternoon, and welcome to the Accelerate Diagnostics Fourth Quarter 2022 Earnings Conference Call. Please note, this event is being recorded.
TUCSON, Ariz. — TUCSON, Ariz. — Accelerate Diagnostics Inc. (AXDX) on Wednesday reported a loss of $14.8 million in its fourth quarter. The Tucson,…
/PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the fourth quarter and year ended December 31, 2022. "In...